Alerts will be sent to your verified email
Verify Email
SURAKSHA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Suraksha Diagnostic offers one-stop integrated solutions for pathology and radiology testing and medical consultation services including X-rays, ultrasonography, computerized tomography, magnetic resonance imaging scans and vaccination services. In addition to integrated pathology and radiology testing services, it also offers omnichannel medical consultation services via online and offline modes to its customers.
Suraksha Diagnostic major competitors are Dr. Lal Pathlabs, Metropolis Health., Thyrocare Tech., Vijaya Diagnostic.
Market Cap of Suraksha Diagnostic is ₹1,544 Crs.
While the median market cap of its peers are ₹10,919 Crs.
Suraksha Diagnostic seems to be less financially stable compared to its competitors.
Altman Z score of Suraksha Diagnostic is 9.63 and is ranked 4 out of its 5 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Sep Dec | ||||||||||||||||
| Investor Presentation | May Aug | Sep Dec | ||||||||||||||||
| Conference Call | Mar Jun | Sep Dec | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
